We examined whether various clinical parameters of prostate cancer, i.e. clinical T stage, PSA recurrence, lymph node metastasis and prostatic capsule invasion, were associated with changes in BIRC6 protein expression. This evidence concerns the gene BIRC6 and metastatic malignant neoplasm in the lymph nodes.